News

McDonald’s, Kraft will bring café experience to store shelves

BY Ryan Chavis

OAK BROOK, Ill. — McDonald's and Kraft are collaborating to bring McDonald's McCafé brand to retail shelves across the United States, beginning in early 2015. The packaged coffees will give consumers a convenient way to enjoy the McCafé experience in their own homes.

"We understand there is huge demand for at-home options, and we've built great success with our McCafé coffee in restaurants. So, it was a natural next step to provide customers with McCafé coffee to enjoy in their own home," said Greg Watson, SVP McDonald's U.S. menu innovation. "We have always been committed to serving delicious, high-quality beverages at a value, and we're happy to provide consumers another great way to enjoy McDonald's McCafé coffees."

Consumers will see the following coffee formats and varieties when the product launches:

  • Roast and Ground: Premium Roast, Breakfast Blend, French Roast, Colombian, Premium Roast Decaf, French Vanilla, Hazelnut and French Roast Whole Bean (12-oz. bag); and
  • Single Cups: Premium Roast, French Roast and Premium Roast Decaf.

The partnership between the two companies places them both in a lucrative position in the at-home coffee category, according to Nina Barton, VPcoffee for Kraft Foods.

"This partnership will allow us to leverage each company's best-in-class capabilities, putting us in a prime position to drive further category growth and deliver one of America's largest, fastest-growing coffee brands to coffee lovers nationwide," Barton said. "By tapping into the loyal McCafé fan base already built by McDonald's and leveraging our deep coffee category expertise here at Kraft, we have the ability to reach a larger audience than ever before, really giving this brand room to thrive."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Carma Labs launches Carmex Cold Sore Treatment

BY Michael Johnsen

 

FRANKLIN, Wis. — Carma Labs on Wednesday announced the launch of Carmex Cold Sore Treatment. According to the company, it is the only over-the-counter cold sore treatment that works on contact to block pain and itch with 10% Benzocaine, while also minimizing the appearance of a sore. The formulation features TriPLEX Formula, which combines three different optical brightener and filler technologies that each provide unique appearance-minimizing benefits.
 
The combination of the three technologies found in TriPLEX Formula advanced technology allows this new formulation to provide cold sore appearance-softening benefits. The technology helps fill in unevenness and helps correct the skin tone of the cold sore. The formula also contains a blend of silicone elastomers, commonly used in high-end skincare products, to give the product a smooth, silky feel. 
 
Carmex Cold Sore Treatment has a suggested retail price of $14.99 (for a 0.07 oz. tube). 
 
According to the National Institutes of Health, herpes simplex virus 1 (HSV-1), the virus that causes cold sores, infects more than half of the U.S. population by the time they reach their 20s. The two biggest physical complaints respondents described were pain, which likely reminds them that the cold sore is there, and the appearance of the sore itself, which can lead to the sufferer feeling isolated and self-conscious, Carma Labs noted.
 
 
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Study: Aspirin not only prevents pain and inflammation, it also helps end inflammation

BY Michael Johnsen

SAN DIEGO — Researchers at the University of California, San Diego School of Medicine concluded that aspirin, in addition to preventing pain and inflammation, actually helps hasten the end of inflammation in a study published this week in the online early edition of PNAS.
 
Non-steroidal anti-inflammation drugs like aspirin, naproxen and ibuprofen all work by inhibiting or killing an enzyme called cyclooxygenase – a key catalyst in production of hormone-like lipid compounds called prostaglandins that are linked to a variety of ailments, from headaches and arthritis to menstrual cramps and wound sepsis.
 
But the San Diego School of Medicine researchers found that aspirin has a second effect: Not only does it kill cyclooxygenase, thus preventing production of the prostaglandins that cause inflammation and pain, it also prompts the enzyme to generate another compound that hastens the end of inflammation, returning the affected cells to homeostatic health.
 
“Aspirin causes the cyclooxygenase to make a small amount of a related product called 15-HETE,” stated senior author Edward Dennis, distinguished professor of Pharmacology, Chemistry and Biochemistry. “During infection and inflammation, the 15-HETE can be converted by a second enzyme into lipoxin, which is known to help reverse inflammation and cause its resolution – a good thing.”
 
Specifically, Dennis and colleagues looked at the function of a type of white blood cells called macrophages, a major player in the body’s immune response to injury and infection. They found that macrophages contain the biochemical tools to not just initiate inflammation, a natural part of the immune response, but also to promote recovery from inflammation by releasing 15-HETE and converting it into lipoxin as the inflammation progresses.
 
Dennis said the findings may open new possibilities for anti-inflammatory therapies by developing new drugs based on analogues of lipoxin and other related molecules that promote resolution of inflammation. “If we can find ways to promote more resolution of inflammation, we can promote health,” he said.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?